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abundance were observed in injured vocal folds compared 
to control. The presence of a mature scar was observed be-
tween 28 and 42 days postinjury. Morphological and ECM 
changes following vocal fold injury in the mouse were gen-
erally consistent with those reported in other animal models, 
particularly the rat, although wound repair in the mouse ap-
pears to occur at a faster rate.    Copyright © 2010 S. Karger AG, Basel 
 Introduction 
  The vocal fold is a unique layered structure consisting 
of epithelium, lamina propria (LP) and the thyroaryte-
noid (TA) muscle [Kurita et al., 1983]. The LP layer con-
tains a rich extracellular matrix (ECM) that underpins 
vocal fold tissue viscoelasticity. The abundance and dis-
tribution of proteins and glycans within this ECM sup-
port vocal fold biomechanical performance for phona-
tion, and their disruption is often detrimental to the voice 
[Gray et al., 1999, 2000]. Significant ECM disruption in 
the context of vocal fold scar is an intractable pathologi-
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 Abstract 
  Mouse experimental models are commonly utilized tools in 
biomedical research but remain underrepresented in vocal 
fold biology, presumably due to the small size of the larynx 
and limited description of the anatomical, cellular and extra-
cellular composition of the vocal folds. In this study, we pro-
vide a whole-mount serial section-based histological de-
scription of vocal fold morphology of wild-type FVB strain 
mice, alongside a histological and immunohistochemical 
(IHC)-based quantitative analysis of extracellular matrix 
(ECM) alteration 1, 7, 14, 28, 42 and 56 days following unilat-
eral vocal fold injury. IHC was specific for procollagen type I, 
collagen type I, collagen type III, collagen type IV, elastin, 
decorin, fibronectin and hyaluronic acid binding protein 2. 
The histological description confirmed the presence of a la-
ryngeal alar structural complex in the mouse, which appears 
to be a morphological feature unique to rodents. The lamina 
propria appeared uniform without evidence of a distinct lay-
er structure as has been reported in larger animals and hu-
mans. Time-dependent alterations in vocal fold morphol-
ogy, ECM organization and ECM protein/glycoconjugate 
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cal condition characterized by severe dysphonia and 
voice handicap [Hirano, 2005; Hansen and Thibeault, 
2006; Welham et al., 2007]. Because of the large variabil-
ity in scarring severity among clinical patients [Hirano et 
al., 2009], and researchers’ inability to systematically con-
trol variables thought to impact treatment outcome, ani-
mal models are critical to progress in this area. In laryn-
geal research, animal model selection has generally been 
driven by a desire to work with a vocal fold structure and 
ECM constitution as close to that of humans as possible. 
While no animal model provides an ideal representation 
of the human vocal fold [Kurita et al., 1983], different spe-
cies hold unique advantages for particular experimental 
applications. 
    Tateya et al. [2005] developed a rat surgical injury 
model to study vocal fold scarring outcomes, based on the 
argument that rats are ubiquitous in biomedical research 
and have a trilayered vocal fold LP, relatively short life 
span, and lower experimental costs than larger animals. 
Rats are also amenable to gene knock-out; however, as the 
technology to achieve knock-out in rats is dependent on 
induced mutagenesis and progeny screening, relatively 
few knock-out models are available [Zan et al., 2003; 
Smits et al., 2006; Cotroneo et al., 2007; van Boxtel et al., 
2008].
  In contrast to rats, gene-manipulated (i.e. knock-out, 
knock-in, knock-down) mouse models are commonly 
utilized tools for studying the role of a specific gene and/
or gene-mediated pathway in a disease of interest. How-
ever, mouse experimental models have had limited use 
in vocal fold research to date, primarily due to the small 
size of the larynx and limited description of the ana-
tomical, cellular and extracellular composition of the 
vocal folds. We recently reported an endoscopic surgical 
methodology for creating vocal fold injuries in FVB 
strain mice [Yamashita et al., 2009]. In order to take full 
advantage of this methodology using gene-manipulated 
models, it is first necessary to have a comprehensive un-
derstanding of the normal morphology and ECM 
changes associated with scar formation in wild-type 
mice. In this study, we used whole-mount serial sections 
to extend previous work describing the gross anatomy 
of the naïve mouse larynx [Thomas et al., 2009], and 
examined the alteration in the abundance of key ECM 
constituents in the LP up to 56 days following unilat-
eral vocal fold injury. 
  Materials  and  Methods 
  This study was performed in accordance with the PHS Policy 
on Humane Care and Use of Laboratory Animals and the Animal 
Welfare Act (7 USC, 2131 et seq.); the animal use protocol was ap-
proved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Wisconsin-Madison.
    Experimental Animals and Surgical Injury 
  Twenty-eight male FVB strain mice (26.2   8   1.2 g; Harlan 
Sprague-Dawley, Indianapolis, Ind., USA) were used in this study. 
Animals were divided into 7 experimental groups (4 animals/
group). Six groups underwent a unilateral (right-sided) vocal fold 
injury procedure followed by sacrifice and laryngeal tissue har-
vest 1, 7, 14, 28, 42 and 56 days postinjury; one group was retained 
as a noninjury control condition. 
    Unilateral vocal fold injuries were created as previously de-
scribed [Yamashita et al., 2009]. Briefly, mice underwent anesthe-
sia induction with 2–3% isoflurane followed by intraperitoneal 
injection of a cocktail containing 50 mg/kg ketamine hydrochlo-
ride (HCl), 4 mg/kg xylazine HCl and 0.05 mg/kg atropine sulfate. 
Additional xylazine HCl was administered topically to the larynx 
and hypopharynx to prevent reflexive glottal closure during the 
surgical procedure. Vocal fold exposure was achieved using a
c u s t o m - f a b r i c a t e d  w i r e  l a r y n g o s c o p e  a n d  t i s s u e  i n j u r y  w a s
performed under endoscopic guidance using a series of custom-
fabricated microinstruments. A right-sided vocal fold injury, con-
sisting of complete removal of the membranous vocal fold 
mucosa with exposure of the TA muscle, was successfully created 
in all experimental animals. None of the mice demonstrated 
physical distress, dyspnea or stridor during postsurgical observa-
tion.
Abbreviations used in this paper
AC arytenoid cartilage
ACA alar cricoarytenoid muscle
ACo anterior commissure
CC cricoid cartilage
DAPI 4,6-diamidino-2-phenylindole dihydrochloride
ECM extracellular matrix
EVG elastica-van Gieson
Gla subglottal gland
HA hyaluronic acid
HABP2 hyaluronic acid binding protein 2
H&E hematoxylin and eosin
IHC immunohistochemistry
LAC laryngeal alar cartilage
LCA lateral cricoarytenoid muscle
LP lamina propria
L-TA lateral thyroarytenoid muscle
M-TA medial thyroarytenoid muscle
RT room temperature
TA thyroarytenoid muscle
TC thyroid cartilage
VF vocal fold Yamashita/Bless/Welham
 
Cells Tissues Organs 2010;192:262–271 264
    Tissue Harvest and Slide Preparation 
 Animals were euthanized by CO  2  asphyxiation. Larynges were 
removed en bloc and dehydrated overnight at 4    °    C in phosphate-
buffered saline containing 25% sucrose. Next, larynges were em-
bedded in optimal cutting temperature compound (Tissue-Tek, 
Sakura Finetech, Tokyo, Japan), snap-frozen using acetone and 
dry ice, and stored at –80    °    C until further use.
  S e r i a l   7-    m cryosections were prepared using a cryostat
(CM-3050 S, Leica, Wetzlar, Germany). One larynx per experi-
mental group was sectioned in the axial plane, and the remaining 
three larynges were sectioned in the coronal plane. Sections were 
air-dried and stored at –20    °    C prior to staining.
    Immunohistochemistry and Histology  
  We employed fluorescent immunohistochemistry (IHC) fol-
lowed by hematoxylin and eosin (H&E) staining to evaluate ECM 
protein abundance and scar formation at successive time points 
following vocal fold injury. IHC was performed for procollagen 
type I, collagen type I, collagen type III, collagen type IV, elastin, 
decorin, fibronectin and hyaluronic acid binding protein 2 
(HABP2). These proteins and glycoconjugates were selected as 
they are known vocal fold ECM constituents and have been shown 
to undergo modulation during wound healing and scar forma-
tion in humans and other animal models [Thibeault et al., 2002; 
Rousseau et al., 2003; Tateya et al., 2005; Hirano et al., 2009]. Two 
midmembranous vocal fold coronal sections (corresponding to 
the anterior-posterior level shown in   fig. 1  C, D) were selected for 
each immunostain from each larynx. Routine H&E staining of 
coronal sections from a normal uninjured mouse and axial sec-
tions from control and injured vocal folds of injured mice at each 
time point were performed to evaluate general vocal fold mor-
phology and structural alteration associated with tissue repair 
and scar formation. 
    Sections intended for IHC were fixed with 4% paraformal-
dehyde for 4 min at room temperature (RT) and treated with 
0.5% Triton X-100 (Sigma-Aldrich, St. Louis, Mo., USA) in 
blocking solution (1:     10; BUF029, Serotec, Raleigh, N.C., USA) 
for 15 min at RT. Image-iT FX signal enhancer (Invitrogen, 
Carlsbad, Calif., USA) was applied for 30 min at RT followed by 
blocking with the above-mentioned blocking solution for 10 min 
at RT. Primary antibodies were applied for 1 h at RT. Relevant 
secondary antibodies were also applied for 1 h at RT. 4   ,6-
Diamidino-2-phenylindole dihydrochloride (2    g/ml  DAPI; 
MP Biomedicals, Santa Ana, Calif., USA) was applied for 20 min 
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  Fig. 1.  Representative H&E-stained images of serial whole-mount 
coronal sections from a wild-type FVB control mouse larynx.   A  –
  L   Panels are ordered from anterior to posterior; the distance be-
tween each panel is approximately 120     m. AC = Arytenoid car-
tilage; ACA = alar cricoarytenoid muscle; ACo = anterior com-
missure; CC = cricoid cartilage; Gla = subglottal gland; LAC = 
laryngeal alar cartilage; LCA = lateral cricoarytenoid muscle;
LP = lamina propria; L-TA = lateral thyroarytenoid muscle;
MTA = medial thyroarytenoid muscle; TA = thyroarytenoid 
  muscle; TC = thyroid cartilage. Asterisk indicates ligament-like 
structure extending from the LAC to the AC. Scale bar: 100    m.   Morphological/ECM Changes following 
Vocal Fold Injury in Mice 
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as a nuclear stain. Slides were washed 3 times, 5 min per wash, 
between each step.
    The primary antibodies used in this study were rabbit anti-
collagen type I (1:    100; ab34710, Abcam, Cambridge, Mass., USA), 
rabbit anti-collagen type III (1:     50; 600-401-105, Rockland, Gil-
bertsville, Pa., USA), rabbit anti-collagen type IV (1:    80;  ab19808, 
Abcam), goat anti-decorin (15     g/ml; AF1060, R&D Systems, 
Minneapolis, Minn., USA), goat anti-elastin (1:     50; sc-17580, San-
ta Cruz Biotechnology, Santa Cruz, Calif., USA), rabbit anti-fibro-
nectin (1:     250; LSL-LB-1027, Cosmo Bio, Tokyo, Japan), rabbit an-
ti-HABP2 (1:     2 0 0 ;  L S - C 1 5 8 3 8 ,  L i f e S p a n  B i o s c i e n c e s ,  S e a t t l e ,  
Wash., USA), and goat anti-procollagen type I (1:    50;  sc-25973, 
Santa Cruz Biotechnology). The secondary antibodies used were 
Alexa Fluor 594 (1:    400; anti-rabbit A-11012 and anti-goat A-11058, 
Invitrogen). Negative controls, for which samples were exposed to 
the secondary antibody in the absence of the primary antibody, 
revealed no immunostain.
    Image Capture and Analysis 
 Stained sections were visualized and images were captured us-
ing a microscope with both bright field and fluorescent capabili-
ties (E600, Nikon, Melville, N.Y., USA) connected to a digital mi-
croscopy camera (DP70, Olympus, Center Valley, Pa., USA). All 
images intended for quantitative analysis were captured with con-
sistent exposure settings.
    Image analysis software (MetaMorph 7.5, Molecular Devices, 
Sunnyvale, Calif., USA) was used to quantify the fluorescent pos-
itive area (in pixels) in the LP of each immunostained image. The 
threshold value for determining a positive signal was determined 
for each ECM protein/glycoconjugate immunostain according to 
its negative control and background signal strength. This thresh-
old was then used consistently across all samples. The LP area was 
defined as deep to the epithelium-basement membrane complex 
(medial boundary) and superficial to the TA muscle (lateral 
boundary). Superior and inferior boundaries were identified by 
narrowing of the LP alongside widening of the adjacent supra- or 
subglottis. Images from adjacent H&E-stained coronal sections 
were used to confirm LP area in cases where the boundary be-
tween the LP and TA muscle was unclear on immunostain (i.e. 
following injury). As reepithelialization was not observed 1 day 
following vocal fold injury, tissue overlying the TA muscle was 
selected as the region of interest in these cases. The number of 
positively stained pixels per LP was normalized to the entire LP 
area and expressed as a percentage. A total of 6 slides (3 animals, 
2 coronal sections/animal) were analyzed per immunostain with-
in each experimental group. Ten percent of immunostained sec-
tions were subjected to intrameasurer and intermeasurer reliabil-
ity analyses. 
  Statistical  Analysis 
  Image analysis data were analyzed using the Mann-Whitney-
Wilcoxon test. Normalized positive immunostain (percent posi-
tive pixels) was compared in the injured (right-sided) vocal fold 
LP at each postinjury time point against the control (i.e. day 0) 
condition; a parallel analysis was performed for the contralateral 
uninjured (left-sided) LP. Intra- and intermeasurer agreements 
were evaluated using Spearman’s rank correlation coefficients (  ). 
An     -level of 0.01 was used for all comparisons; all p values were 
two-sided.
  R e s u l t s  
  Anatomical Features of Mouse Vocal Folds 
  We evaluated the general morphology of the naïve 
FVB strain mouse larynx using routine histological prep-
aration and H&E staining.   Figure 1   contains representa-
tive serial coronal sections, beginning at the anterior 
commissure (  fig. 1  A), which forms the anterior border of 
both vocal folds, and moving posteriorly. The right vocal 
fold is predominantly featured in this figure. The vocal 
fold and superior structures were covered by stratified 
squamous epithelium, which transitioned to pseudostrat-
ified ciliated epithelium in the subglottis. The TA muscle, 
which operates to shorten the vocal fold, was identified 
with medial and lateral compartments (M-TA and L-TA 
in   fig. 1  B, E). The laryngeal alar cartilage (LAC), an ana-
tomic feature unique to rodents, was located superior to 
the vocal fold (  fig. 1  C). From an endoscopic superior ori-
entation, the shape of this cartilage resembled an inverted 
V. The alar cricoarytenoid muscle (ACA) ( fig. 1 E) was lo-
cated superior to the TA and ran through the LAC to the 
arytenoid (AC in   fig. 1  H, J, L) and cricoid (CC in   fig. 1  J, 
L) cartilages. The LP was located in the region between 
the M-TA and epithelium ( fig. 1 C, E). An eosinophilic lig-
ament-like structure (asterisk in  fig. 1 E, F) was identified 
extending from the LAC to the AC. 
    Alteration of Matrix Constituents following Vocal 
Fold Injury 
  We induced a unilateral vocal fold surgical injury and 
evaluated change in the abundance of ECM constituents 
procollagen type I, collagen type I, collagen type III, col-
lagen type IV, elastin, decorin, fibronectin and HABP2 
over time. IHC and quantitative image analysis revealed 
significant alteration in ECM organization and abun-
dance at 1, 7, 14, 28, 42 and 56 days postinjury compared 
to uninjured control (  fig. 2,     3  ). Intrameasurer      was 0.94; 
intermeasurer      was 0.81.
  All ECM constituents were detected in the naïve vocal 
fold LP; however, procollagen type I ( fig. 2 A) and collagen 
type IV (  fig. 2  D) demonstrated a relatively weak immu-
nostain under this condition (procollagen I is a collagen 
type I precursor and is therefore expected to be most 
abundant during periods of active matrix remodeling, 
collagen type IV is primarily a basement membrane pro-
tein and is therefore expected to be sparsely distributed 
in the naïve LP). Following vocal fold injury, procollagen 
type I abundance increased significantly at day 1 only 
(  fig. 2  A). Collagen type I (  fig. 2  B) and collagen type IV 
(  fig. 2  D) exhibited similar patterns of decreased abun- Yamashita/Bless/Welham
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  Fig. 2.   Representative IHC images and quantitative analysis of 
procollagen type I (  A  ), collagen type I (  B  ), collagen type III (  C ), 
and collagen type IV (  D  ) in uninjured control and injured vocal 
fold LP over time. Normalized abundance is expressed with re-
spect to total LP area (indicated by a white dashed line). Error bars 
represent standard deviations and asterisks denote statistically 
significant differences (p   !   0.01) from the control group (day 0). 
VF = Vocal fold. Scale bar: 200    m.   Morphological/ECM Changes following 
Vocal Fold Injury in Mice 
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  Fig. 3.   Representative IHC images and quantitative analysis of 
elastin (  A  ), decorin (  B  ), fibronectin (  C  ), and HABP2 (  D  ) in unin-
jured control and injured vocal fold LP over time. Normalized 
abundance is expressed with respect to total LP area (indicated 
by a white dashed line). Error bars represent standard deviations 
and asterisks denote statistically significant differences (p   !  
0.01) from the control group (day 0). VF = Vocal fold. Scale bar: 
200    m.  Yamashita/Bless/Welham
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dance at day 1 compared to control, maximum abun-
dance at day 7, and gradually decreasing abundance over 
the remaining time points. Collagen type III ( fig. 2 C) and 
decorin (  fig. 3  B) exhibited a pattern of decreased abun-
dance on day 1, followed by a sustained increase in abun-
dance beginning on day 7. Elastin abundance was vari-
able across all time points with no significant differences 
noted (  fig.  3  A). Fibronectin demonstrated increased 
abundance between days 1 and 42 (  fig. 3  C). HABP2 ex-
hibited increased abundance between days 1 and 14 
( fig. 3 D).
    Morphological Changes following Vocal Fold Injury 
  We evaluated morphological changes following vocal 
fold injury using routine histological preparation and 
H&E staining.   Figure 4   contains representative H&E-
stained whole-mount axial sections of a naïve control lar-
ynx and larynges 1, 7, 14, 28 and 42 days following uni-
lateral vocal fold injury. Consistent with the coronal sec-
tions presented in   figure 1  , the naïve control sample 
( fig. 4 A) was characterized by a relatively simple LP struc-
ture. One day postinjury, the injured vocal fold was char-
acterized by a fibrin clot, inflammatory cell infiltration 
and absent epithelium (  fig. 4  B). Reepithelialization oc-
curred by 7 days postinjury (  fig. 4  C). By 28 days post-
injury, the injured LP had contracted and appeared 
densely eosinophilic ( fig. 4 E), consistent with mature scar 
formation. H&E-stained whole-mount coronal sections 
from additional mice at each time point revealed compa-
rable histopathology (data not shown).
  Discussion 
 Inagi et al. [1988] provided the first comprehensive de-
scription of rat laryngeal anatomy. They identified and 
named the LAC, which is not present in larger animals 
and humans, and provided a detailed account of the rat 
intrinsic laryngeal muscles. Tateya et al. [2005, 2006b] 
extended this work by introducing a vocal fold injury and 
M-TA
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D E F
  Fig. 4.   Representative H&E-stained images of whole-mount axial 
sections from an uninjured control mouse larynx and unilater-
ally injured mice larynges at 1, 7, 14, 28 and 42 days postinjury.
A Uninjured control. B One day postinjury. C Seven days postin-
jury. D Fourteen days postinjury. E Twenty-eight days postinjury. 
Arrow indicates dense eosinophilic region and LP contraction.
F Forty-two days postinjury. H&E-stained whole-mount coronal 
sections from additional mice at each time point revealed compa-
rable histopathology (data not shown). AC = Arytenoid carti-
lage; LP = lamina propria; L-TA = lateral thyroarytenoid muscle; 
M-TA = medial thyroarytenoid muscle; TC = thyroid cartilage. 
Asterisk indicates fibrin clot and infiltration of inflammatory 
cells. Scale bar: 200 μm.
   Morphological/ECM Changes following 
Vocal Fold Injury in Mice 
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scar model in the rat, which has been adopted by several 
groups in the investigation of ECM alteration during vo-
cal fold wound healing. Laryngeal research using a mouse 
model is rare and to date has been primarily limited to 
nonsurgical studies [Renne et al., 1992; Renne and Gide-
on, 2006; Abdelkafy et al., 2007; Marques et al., 2007; 
Hamamoto et al., 2008; Nishio et al., 2008; Thomas et al., 
2008, 2009], presumably due to the inherent challenges of 
working with such small tissue samples and limited 
knowledge regarding normal morphology. These limita-
tions have delayed the adoption of genetically manipu-
lated mouse models in laryngeal research; however, re-
cent advances indicate that the application and surgical 
manipulation of these models are feasible. We recently 
reported a methodology for endoscopic laryngeal surgery 
in FVB strain mice [Yamashita et al., 2009], and Thomas 
et al. [2009] recently described gross laryngeal cartilage 
and muscle structure in C57/BL6J strain mice. This study 
expands upon these previous reports by providing a 
whole-mount serial section-based histological descrip-
tion of vocal fold morphology of wild-type FVB strain 
mice, alongside IHC-based quantitative analysis of ECM 
alteration up to 56 days following unilateral vocal fold 
injury.
    Similar to rats, mice have an LAC and a pair of ACAs, 
which course from the LAC to the CC and AC (  fig. 1  E). 
They also have an eosinophilic ligament-like structure 
extending from LAC to the AC (  fig. 1  F). The functional 
significance of this alar structural complex in rodents is 
unknown; however, based on its anatomical position, it 
may function to protect the airway during swallowing by 
shortening the distance between each AC and the epiglot-
tis. Our histology and IHC data suggest that the mouse 
LP is relatively uniform without evidence of a distinct 
layer structure as has been reported in larger animals and 
humans [Kurita et al., 1983].
    We employed fluorescent IHC to measure the abun-
dance of eight ECM constituents in naïve and injured vo-
cal folds over time. Procollagen type I is a precursor of 
collagen type I and therefore indicates new collagen type 
I synthesis. Collagen type I is a primary fibrous protein 
in connective tissue and is the most abundant collagen 
subtype in the human body. It demonstrates preferential 
localization to the most superficial and deep regions of 
the human LP and is believed to provide tensile strength 
during vocal fold oscillation [Tateya et al., 2006a]. Col-
lagen type III is the most abundant and uniformly dis-
tributed collagen subtype in the vocal fold LP [Tateya et 
al., 2006a]. It forms a reticular fibrous network and plays 
a role in wound healing in the early stages following in-
jury [Stephens and Thomas, 2002]. Collagen type IV is a 
nonfibrous protein and is highly abundant in the base-
ment membrane region [Gray et al., 1994; Tateya et al., 
2006a]. Our observation of reduced collagen type IV 
abundance 1 day postinjury is consistent with epithelial 
disruption induced by our surgical procedure, whereas 
the high level of collagen type IV 7 days postinjury is con-
sistent with reepithelialization. Elastin is a fibrous pro-
tein and a key component of elastic fiber. It confers elas-
ticity to the vocal fold LP and is therefore critical to bio-
mechanical tissue performance [Gray et al., 2000]. The 
antibody employed in this study reacts to both tropoelas-
tin, which is a precursor of elastin, and mature elastin. 
Decorin is a proteoglycan and a modulator of collagen 
fibrillogenesis [Reed and Iozzo, 2002]. Elevated decorin 
levels postinjury, as observed in our study, are associated 
with scar formation via regulation of the transforming 
growth factor-     pathway; in contrast, reduced decorin 
has been associated with scarless wound healing [Beanes 
et al., 2001]. Fibronectin is a glycoprotein and functions 
as an adhesion molecule for cell-to-cell and cell-to-ECM 
interaction [Ruoslahti, 1988]. HABP2 binds to the glycos-
aminoglycan hyaluronic acid (HA) and infers HA abun-
dance, which in turn is a primary contributor to vocal 
fold LP viscosity [Gray et al., 1999]. Each of these ECM 
constituents was detected in the mouse LP and the major-
ity demonstrated alteration in abundance over time in 
response to tissue injury. This suggests that even though 
a distinct LP layer structure is not present, the mouse is 
useful as a model for ECM modulation and scar forma-
tion in response to vocal fold injury.
    Previous work addressing vocal fold ECM alteration 
and chronic scar formation has been reported in human 
patients, and canine, rabbit and rat animal models, using 
a variety of ECM detection methods. Data from human 
patients 3–13 months following vocal fold tissue resec-
tion suggest that while most patients show elevated col-
lagen abundance, ECM modulation varies widely across 
individuals, possibly due to the extent of LP resection and 
heterogeneity in individual wound healing [Hirano et al., 
2009]. Rousseau et al. [2003] introduced a canine scarring 
model and reported increased procollagen type I 2 
months postinjury (IHC), increased and disorganized 
collagen 6 months postinjury [elastica-van Gieson (EVG) 
stain], decreased and disorganized elastic fibers at 2 and 
6 months postinjury (EVG stain), and no change in HA 
at either time point (Alcian blue stain with hyaluronidase 
digestion control). Thibeault et al. [2002] utilized a rabbit 
model and reported increased procollagen type I (IHC), 
decreased but highly disorganized collagen (trichrome  Yamashita/Bless/Welham
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strain), decreased and shortened elastic fibers (EVG 
stain), and no change in HA (colloidal iron stain with hy-
aluronidase digestion control) 2 months postinjury. A 
follow-up study 6 months postinjury in the rabbit report-
ed elevated collagen (EVG stain) and no change in pro-
collagen, elastin and HA abundance compared to nonin-
jured control [Rousseau et al., 2004]. In comparing our 
data to that generated in humans and larger animals, it is 
important to note that the temporal progression of wound 
healing and ECM remodeling events is known to differ 
between rodents and larger animals [Tateya et al., 2005, 
2006b]. Additionally, the use of antibodies against spe-
cific protein/glycoconjugate subtypes in this study differs 
from the general histology staining procedures reported 
above. Regardless of these differences, we observed early 
upregulation of procollagen type I, followed by subse-
quent upregulation of collagen types I, III and IV, which 
is consistent with the general trend for procollagen and 
collagen reported in the canine and rabbit. Also compa-
rable to previous reports, HA (inferred by HABP2) abun-
dance at later postinjury time points was comparable to 
control in our dataset. Inconsistent with the canine and 
rabbit, we observed no significant alteration in elastin 
abundance. Finally, we observed elevated abundance of 
decorin and fibronectin postinjury, two ECM glycocon-
jugates that were not investigated in these earlier reports. 
    With the exception of HA, our findings in mice are 
generally consistent with data reported by Tateya et al. 
[2005] 14–84 days postinjury in a rat model. They ob-
served increased collagen type I and III abundance at all 
postinjury time points (IHC); similar to our findings, 
collagen type I abundance tapered following an initial 
peak, whereas collagen type III abundance was sustained 
throughout the observation period. Fibronectin abun-
dance increased at 14 and 28 days postinjury (IHC), and 
HA abundance decreased at all postinjury time points 
(Alcian blue stain with hyaluronidase digestion control). 
Our observation of initial HABP2 upregulation followed 
by a return to control levels is consistent with other re-
ports showing that early accumulation of HA functions 
to stabilize the ECM, stimulate cell infiltration and mi-
gration and modulate fibrin degradation [Weigel et al., 
1986; Chen, 2002]. Also consistent with our data and 
these reports, Thibeault et al. [2004] reported general 
downregulation of HA in the first 15 days following vocal 
fold injury in rabbits, but noted peak abundance compa-
rable to uninjured control at 5 days postinjury. 
    We observed a fibrin clot and infiltration of inflam-
matory cells 1 day postinjury and reepithelialization by 7 
days postinjury. These observations are consistent with 
our previous report [Yamashita et al., 2009] and suggest 
that vocal fold reepithelialization in mice occurs more 
rapidly than the 7–14 days reported in rats [Tateya et al., 
2006b]. The LP appeared contracted and eosinophilic by 
14 days and typical morphological features of scarred vo-
cal folds were evident by 28 days postinjury. Together, our 
histological and IHC data suggest that it takes 28–42 days 
to form a mature scar in the mouse LP. These findings 
represent a useful comparative dataset for evaluating 
acute and chronic injury outcomes in genetically manip-
ulated mice.
    Our findings demonstrate that a mouse model is well 
suited to the study of ECM alteration associated with vo-
cal fold injury and scar formation. Our previously report-
ed surgical methodology was successful in creating an 
acute injury and chronic scar in the mouse that was char-
acterized using conventional histology and IHC. Further, 
our findings suggest that data from other species cannot 
be used to determine the temporal progression of wound 
healing and ECM remodeling events in the mouse, be-
cause although the events observed in this study are gen-
e rall y  c o n s i s t e n t  wi th  th o s e  r e p o rt e d  in  o th e r  anim al  
models (particularly rat), wound repair in the mouse oc-
curs at a faster rate. 
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